Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial
Bear, Harry D, Prof, Tang, Gong, PhD, Rastogi, Priya, MD, Geyer, Charles E, Prof, Liu, Qing, PhD, Robidoux, André, Prof, Baez-Diaz, Luis, MD, Brufsky, Adam M, Prof, Mehta, Rita S, Prof, Fehrenbacher, Louis, MD, Young, James A, MD, Senecal, Francis M, MD, Gaur, Rakesh, MD, Margolese, Richard G, MD, Adams, Paul T, MD, Gross, Howard M, MD, Costantino, Joseph P, Prof, Paik, Soonmyung, Prof, Swain, Sandra M, Prof, Mamounas, Eleftherios P, MD, Wolmark, Norman, Prof
Published in The lancet oncology (01.09.2015)
Published in The lancet oncology (01.09.2015)
Get full text
Journal Article
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
Paterson, Alexander HG, Prof, Anderson, Stewart J, Prof, Lembersky, Barry C, MD, Fehrenbacher, Louis, MD, Falkson, Carla I, MD, King, Karen M, MD, Weir, Lorna M, MD, Brufsky, Adam M, Prof, Dakhil, Shaker, MD, Lad, Thomas, MD, Baez-Diaz, Luis, MD, Gralow, Julie R, MD, Robidoux, André, MD, Perez, Edith A, Prof, Zheng, Ping, MD, Geyer, Charles E, MD, Swain, Sandra M, Prof, Costantino, Joseph P, Prof, Mamounas, Eleftherios P, MD, Wolmark, Norman, Prof
Published in The lancet oncology (01.07.2012)
Published in The lancet oncology (01.07.2012)
Get full text
Journal Article